500
Participants
Start Date
October 31, 2001
Primary Completion Date
November 30, 2002
Study Completion Date
November 30, 2002
zoledronic acid
Virginia Physicians, Inc, Richmond
Osceola Cancer Center, Kissimmee
Hematology-Oncology Associates PC, Albuquerque
New Mexico Oncology Hematology Consultants, Albuquerque
Nevada Cancer Center, Las Vegas
Stockton Hematology Oncology Medical Group, Stockton
Hematology Oncology Associates, PC, Medforo
Lead Sponsor
Novartis
INDUSTRY